AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
184.52
-2.06 (-1.10%)
Nov 3, 2026, 11:41 AM EST - Market open
AstraZeneca Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of $206.66. The average 1-year stock price forecast is 12.00% higher than the current stock price, while the lowest is $158 (-14.37%) and the highest is $240 (+30.07%).
Price Target: $206.66 (+12.00%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Hold | 1 | 2 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 10 | 10 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $265 → $275 | Buy | Maintains | $265 → $275 | +48.89% | Nov 3, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $217 | Buy | Maintains | $217 | +17.66% | Nov 2, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $157 | Hold | Maintains | $157 | -15.03% | Nov 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $194 → $204 | Buy | Maintains | $194 → $204 | +10.76% | Nov 2, 2026 |
| Citi | Citi | Buy Maintains $249 → $253 | Buy | Maintains | $249 → $253 | +37.27% | Nov 2, 2026 |
Financial Forecast
Revenue This Year
63.35B
from 58.74B
Increased by 7.85%
Revenue Next Year
67.38B
from 63.35B
Increased by 6.36%
EPS This Year
10.22
from 9.16
Increased by 11.62%
EPS Next Year
11.36
from 10.22
Increased by 11.07%
EPS and Forward PE are based on non-GAAP adjusted numbers.